Related Experiment Video
Updated: May 27, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and
Domenico Corrado1, Francesca Graziano1,2, Barbara Bauce1
1Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Insights
The new Padua Classification for cardiomyopathies integrates genetics and cardiac imaging. This approach aims to improve diagnosis and tailor treatments for better patient outcomes.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Cardiomyopathies are complex heart muscle diseases with diverse causes and presentations.
- Current classifications may not fully integrate pathobiological and clinical aspects.
Purpose of the Study:
- To introduce and describe the novel Padua Classification for cardiomyopathies.
- To highlight its basis in pathobiology and clinical morpho-functional features.
- To underscore its potential for improved diagnostic accuracy and disease-specific therapies.
Main Methods:
- The Padua Classification integrates pathobiological data (genetics, molecular biology, pathology) with clinical features.
- It utilizes morpho-functional and structural ventricular remodelling assessed by cardiac magnetic resonance.
- Cardiomyopathies are categorized into three main groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic.
Main Results:
- The classification provides a designation combining anatomical and functional features for each cardiomyopathy.
- It accounts for both genetic and non-genetic etiologic variants within each group.
- This systematic approach facilitates a more comprehensive understanding of individual cardiomyopathies.
Conclusions:
- The Padua Classification offers a novel, integrated framework for understanding cardiomyopathies.
- It is expected to enhance diagnostic precision.
- The classification supports the development of targeted, disease-specific therapeutic strategies to improve patient management and outcomes.
Abstract:
The newly proposed classification of cardiomyopathies, referred to as 'the Padua Classification', is based on both pathobiological basis (genetics, molecular biology, and pathology) and clinical features (morpho-functional and structural ventricular remodelling as evidenced by cardiac magnetic resonance). Cardiomyopathies are grouped into tree main categories and characterized by a designation combining both 'anatomical' and 'functional' features: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic; each cardiomyopathy group includes either genetic or non-genetic aetiologic variants. This novel approach aims to enhance the diagnostic accuracy and to support 'disease-specific' therapeutic strategies, with the objective to improve patient management and outcome.
Related Concept Videos
Pathophysiology of Heart Failure
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Mechanism of Cardiac Arrhythmias
Pathophysiology of Cardiac Performance
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

